Author:
Yajima Yasumi,Takenoshita Seiichi,Asao Takayuki,Shinozaki Kei,Nagamachi Yukio
Publisher
The Japanese Society of Strategies for Cancer Research and Therapy
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference23 articles.
1. 1) Zamkoff KW, Hudson J, Groves ES, Childs A, Konrad M, Rudolph AR. A Phase I trial of recombinant human macrophage colony-stimulating factor by rapid intravenous infusion in patients with refractory malignancy. J Immunother, 11: 103-110, 1992.
2. 2) Warren MK, Ralph P, Stanley ER. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol, 137: 2281-2285, 1986.
3. 3) Munn DH, Cheung N-KV. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med, 172: 231-237, 1990.
4. 4) Suzu S, Yanai N, Saito M, Kawashima T, Motoyoshi K. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor. Jpn J Cancer Res, 81: 79-84, 1990.
5. 5) Sanda MG, Bolton E, Mule JJ, Rosenberg SA. In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-depended cytotoxicity of tumor cells. J Immunother, 12: 132-137, 1992.